Strategic and Practical Pharmacoeconomics

American Conference Institute’s inaugural National Forum on Strategic and Practical Pharmacoeconomics will provide the necessary and practical information and analysis for all those attempting to fairly determine the value and efficacy of a drug or biotech product.

Washington D.C. shareholder Edward John Allera will present a program titled "Laying the Foundation for Continued Success: How the Pharmaceutical and Biotechnology Industries Can Determine the Value and Price of Prescription Drug Products" on day one of the seminar. As the concept of pharmacoeconomics begins to crystallize, pharmaceutical and biotech companies have a unique opportunity to shape the foundation of this complex concept. How will the “value” of a therapy be measured? And by whom? What methods will be acceptable in calculating value? How will variables be measured? Who should be solicited in the federal government to deliver these messages and standards to? These critical questions and others will pave the way for pharma and biotech companies to secure placement on formularies – both private and public – and to continue to thrive as an industry. Allera, former associate chief counsel at FDA, and Corry, former special assistant to the administrator at CMS, help to design the most current roadmap that will determine the direction of this critical issue.

The seminar will be held on Monday, October 15 and Tuesday, October 16, 2007, at the Warwick New York Hotel in New York City. For more information, call 888-224-2480.